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INTRODUCTION:  Metachronous  metastatic  spread  of clinically  localized  renal  cell  carcinoma  (RCC)  affects
almost 1/3  of  the patients.  They  occur  most  frequently  in  lung,  liver,  bone  and  brain.  Isolated  omental
metastasis  of  RCC  has not  been  reported  so  far.
CASE PRESENTATION:  A  62-year-old  patient  previously  diagnosed  and treated  due  to  pulmonary  sarcoido-
sis  has  developed  an omental  metastatic  lesion  13 years  after having  undergone  open  extraperitoneal
partial  nephrectomy  for T1  clear-cell  RCC.  Constitutional  symptoms  and  imaging  ﬁndings  that  were
attributed  to the  presence  of  a sarcomatoid  paraneoplastic  syndrome  triggered  by  the  development  this
metastatic  focus  complicated  the  diagnostic  work-up.  Biopsy  of  the [18F]-ﬂuorodeoxyglucose  (+)  lesions
conﬁrmed  the  diagnosis  of  metastatic  RCC  and  the  patient  was  managed  by  the  resection  of the  omental
mass  via  near-total  omentectomy  followed  by  targeted  therapy  with  a tyrosine  kinase  inhibitor.
DISCUSSION:  Late  recurrence  of  RCC has  been  reported  to  occur  in  10–20%  of  the  patients  within  20 years.
Therefore  lifelong  follow  up of  RCC  has  been  advocated  by  some  authors.  Diffuse  peritoneal  metastases
have  been  reported  in certain  RCC  subtypes  with  adverse  histopathological  features.  However,  isolated
omental metastasis  without  any  sign  of peritoneal  involvement  is  an  extremely  rare  condition.
CONCLUSION:  To  our knowledge,  this  is  the  ﬁrst reported  case  of metachronously  developed,  isolated
omental  metastasis  of an  initially  T1  clear-cell  RCC.  Constitutional  symptoms,  despite  a  long  interval  since
nephrectomy,  should  raise  the  possibility  of  a paraneoplastic  syndrome  being  associated  with  metastatic
RCC.  Morphological  and  molecular  imaging  studies  together  with  histopathological  documentation  will
be diagnostic.
© 2016  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
The incidence of renal cell carcinoma (RCC) has been rising,
hich includes both early stage and late stage disease [1]. Approxi-
ately 85% of all RCCs are of clear cell histology [2]. About 20–30% of
atients have metastatic disease at the time of diagnosis, and about
0–40% of patients with clinically localized disease at diagnosis will
ventually develop metastases [3]. RCC often metastasizes to the
ung, bone, liver and brain. Herein, we report a case with isolated
mental metastasis of RCC that has developed metachronously 13
∗ Corresponding author at: VKF American Hospital, Güzelbahc¸ e Sk. 20, Depart-
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ttp://dx.doi.org/10.1016/j.ijscr.2016.02.008
210-2612/© 2016 The Authors. Published by Elsevier Ltd. on behalf of IJS Publishing 
reativecommons.org/licenses/by-nc-nd/4.0/). BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
years after the initially localized disease was managed by partial
nephrectomy.
2. Description of the case
A currently 62-year-old male presented with decreased force
of urinary stream, frequency, malaise, loss of apatite, difﬁculty in
breathing and nonproductive cough. He was  treated due to pul-
monary sarcoidosis in the past and apart from hypertension he did
not have any systemic comorbidity. He was using bronchodilators
on demand due to airway-related problems and he received corti-
costeroids due to sarcoidosis in the past. He had undergone open
extraperitoneal partial nephrectomy elsewhere due to T1 clear-cell
RCC, 13 years ago. He also reported transurethral resection of the
prostate (TURP) and consequent ofﬁce-based urethral dilatation
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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tig. 1. Sagittal fat saturated T2-weighted magnetic resonance image. A round, well-c
rinary  bladder inferiorly.
rocedures due to post-TURP urethral stricture. He had complied
ith the postoperative surveillance protocol of RCC and until 2013
here was no sign of recurrence or metastasis.
Imaging workup began with an abdominal ultrasound, demon-
trating a solid round mass superolateral to the urinary bladder
ith nonspeciﬁc heterogeneous echotexture. Magnetic resonance
maging (MRI) conﬁrmed this mass as a well-circumscribed struc-
ure abutting the superolateral urinary bladder, with a thin
ut preserved intervening fat plane between it and the urinary
ladder (Fig. 1). For further staging, [18F]-ﬂuorodeoxyglucose
FDG) positron emission tomography-computed tomography (PET-
T) scan was  undertaken, demonstrating the index supravesical
esion to be FDG-hypermetabolic, as well as innumerable FDG-
ypermetabolic lesions with an osseous, renal, pleural, and
ymphatic distribution (Fig. 2). Percutaneous biopsy was  directed
o both the index supravesical lesion as well as the most hyper-
etabolic extravesical site (right iliac bone lesion). Histopathology
f the supravesical specimen revealed clear cell RCC (representing
elayed isolated omental metastasis) while the osseous specimen
as interpreted as sarcomatoid reaction (Fig. 3).
Then, we made a consultation with the Pulmonary Medicine
epartment and the advice given by them was to remove the
etastatic lesion since widespread FDG (+) lesions and accom-
anying constitutional symptoms may  be a sort of paraneoplastic
yndrome, which can be seen quite often in RCC. We  opted for an
pen surgery to remove the mass and during exploration it was
ound to be located within the omentum as a clearly palpable, iso-
ated nodularity (Fig. 4). Neither the intestinal segments nor the
eritoneum seemed to be affected by the metastatic spread. We
erformed a near-total omentectomy and excised the mass with
lear margins. In the same session, we performed direct visual
ndoscopic internal urethrotomy due to bulbomembranous ure-
hral stricture which seemed explanatory for the emptying phasescribed, T2-heterogeneous signal intensity mass (arrow) displaces the anteroinferior
lower urinary tract symptoms (LUTS). Histopathological examina-
tion ﬁndings in the omental mass were concordant with the tru-cut
biopsy result (Fig. 5). After having the opinions of Medical Oncology
and Pulmonary Medicine specialists, the patient was scheduled for
adjuvant targeted therapy with a tyrosine kinase inhibitor (suni-
tinib).
3. Discussion
Late recurrence is one of the biological behaviors of RCC. It has
been reported that the recurrence rate 5 years after surgery is 8.8%
and the rate after 10 years is 11% [4,5]. A previous study of patients
with RCC who  did not develop recurrence within a 10-year follow-
up observation period reported that late recurrence rates were 10.5
and 21.6% at 15 and 20 years, respectively [6]. Therefore, some
authors have highlighted the importance of postoperative surveil-
lance and recommended life-long follow-up of RCC after the initial
treatment [6]. Supporting this phenomenon; our case, who  had pT1
clear cell RCC at the time of diagnosis, has developed an isolated
omental metastasis 13 years following partial nephrectomy.
Some aggressive RCC subtypes with adverse histopathological
features (sarcomatoid differentiation etc.) can present with dif-
fuse peritoneal metastases involving the omentum [7,8]. However,
development of metachronous omental metastasis(es), particulary
in the absence of diffuse peritoneal involvement, is an extremely
rare condition in the natural history of RCC. Win  et al. have recently
reported a patient with an initially T3N0M0 chromopobe RCC,
who developed an interaortocaval lymph node enlargement 1 year
after laparoscopic radical nephrectomy [9]. They have inciden-
tally discovered an additional omental metastatic deposit while
removing this interaortocaval mass. Despite surgical excision and
adjuvant therapy with tyrosine kinase inhibitors, the omental nod-
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Fig. 2. [18F]-Fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) (A) Maximum intensity projection (MIP) image shows innumerable
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arcomatoid reaction (thin arrow).
les recurred and they were able to detect this recurrence via FDG
vidity on surveillance PET/CT studies [9].
RCC is unique for its association with various paraneoplastic
yndromes. These can range from those manifesting as constitu-
ional symptoms (ie., fever, cachexia, and weight loss) to those
hat result in speciﬁc metabolic and biochemical abnormalities
ie., hypercalcemia, nonmetastatic hepatic dysfunction, amyloido-
is, etc.). The constitutional symptoms of our patient was  initially
ttributed to the progression of sarcoidosis. However, disseminated
sseous involvement is quite rare in sarcoidosis and in the absence
istological proof of non-caseating granulomata on biopsy spec-
mens it would not be possible to conclude upon the diagnosis
f sarcoidosis. Moreover, the probability of metastatic dissemina-
ion must be evaluated in a patient who has been operated due
o localized RCC. On the other hand, Willis et al. have reported that
arcoidosis and RCC can coexist in the same individual. In their case,
he undiagnosed condition of sarcoidosis complicated the staging
f bilateral RCC. Prior to the initiation of immunotherapy due to the
nitial diagnosis of mRCC, they also performed an FDG PET/CT scan
nd the difference in metabolic activity between the primary site
f disease and the presumed metastatic disease suggested the pos-
ibility of two separate disease processes. The patient underwent
ilateral partial nephrectomies and was ultimately diagnosed with
tage T1 bilateral RCC. Demonstration of non-caseating granulo-
as  on pulmonary nodules conﬁrmed the diagnosis of coexistent
arcoidosis in this case [10].
This patient underwent extensive imaging work-up in an
ffort to exclude RCC metastasis, however the summary of non-nd below the diaphragm. (B) CT soft tissue window, Fusion PET-CT, and CT bone
Focal hypermetabolic right iliac bone lesion was also targeted for biopsy revealing
invasive studies provided equivocal results. For example, initial
ultrasound and MRI  ﬁndings revealed the solitary index lesion
(supravesical mass). However, the subsequent FDG PET/CT scan
demonstrated the FDG-hypermetabolic index lesion but also innu-
merable disseminated FDG-hypermetabolic foci. Moreover, FDG
PET-CT is known to carry some limitation in the evaluation of
RCC (unless the RCC is high grade). Therefore, combining the
known pulmonary and surgical history with the patient’s delayed
presentation and dramatic PET-CT ﬁndings in the context of benign-
appearing renal fossae, tissue sampling was deemed necessary to
guide the next steps in care. Eventually, we thought that most of
the presenting symptoms, except emptying phase LUTS, and the
FDG-hypermetabolic lesions should be considered as a component
of a sarcomatoid paraneoplastic syndrome triggered by metastatic
progression of an initially localized RCC.
Surgical resection of the primary tumor and metastatic deposits
continues to play an important role in managing patients with
mRCC when aiming for complete remissions, the likelihood of
which is further supplemented with the addition of systemic tar-
geted therapy. Therefore, after the removal of omental metastasis,
our patient was scheduled to receive targeted therapy with suni-
tinib.
4. ConclusionsTo our knowledge, this is the ﬁrst reported case of metachronous
isolated omental metastasis of an initially T1 clear-cell RCC.
Metastatic spread can develop many years after the surgical
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Fig. 3. (A) Histopathology of the suprapubic mass demonstrate a neoplasm composed of cells with clear vacuolated cytoplasm and hyperchromatic small nuclei (H&E, ×90).
(B)  Immunohistochemically, tumor cells show nuclear positivity with PAX8 (IHC stain ×150). (C) Immunohistochemically, tumor cells show strong, diffuse positivity with
CD10  (IHC stain ×150). (D) H&E stained sections of the neddle biopsy from the iliac bone showing granulomatous inﬂammation (×150).
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Fig. 4. Macroscopic appearance of the omental metastatic deposit. Note its prominent vascular supply and collateral vascular network covering its surface.
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reatment of localized RCC. Constitutional symptoms may  be a sign
f paraneoplastic syndrome that was triggered by RCC progression.
oexistent medical conditions, such as sarcoidosis as in our case,
ay complicate the diagnostic process. Morphological and func-
ional imaging studies together with histopathological assessment
f biopsy materials are necessary to conﬁrm the diagnosis of mRCC
nd rule out other systemic disease processes.
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